New drug trial offers hope for Tough-to-Treat cancers
NCT ID NCT05785039
Summary
This study is testing an experimental drug called BL-B01D1 in people with advanced solid tumors that have spread or can't be removed by surgery, including cancers of the urinary system. The main goals are to find a safe and effective dose and to see if the drug can shrink tumors in patients whose cancer has worsened despite standard treatments. Researchers will also measure how long the drug works and how the body processes it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY SYSTEM TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University ShangHai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.